Health systems should take the lead in fixing the broken prior authorization process, said Jeff Balser, CEO of Vanderbilt University Medical Center, during a recent conference. He highlighted AI, better workflows and centralized support as ways to reduce delays.
Health systems should take the lead in fixing the broken prior authorization process, said Jeff Balser, CEO of Vanderbilt University Medical Center, during a recent conference. He highlighted AI, better workflows and centralized support as ways to reduce delays.
Join us onDecember 18th and hear from Lucas Ferandez, Director, Medical Devices at Meta as he details how the company embeds quality processes into existing systems, simplifies QMS management and automates documentation workflows within existing tools to enhance consistency and speed. Sign up to save your spot!
[Sponsored] Pharmacy benefit managers are under scrutiny for their business practices that are often blamed for contributing to the rising costs of prescription drugs in America. But one PBM is paving another way that alters the traditional operating model.
The high dose of Eli Lilly's retatrutide led to an average 28.7% loss in body weight measured at 68 weeks. These Phase 3 results are the first from the experimental obesity drug's broad clinical trial program, which is on track to yield seven data readouts in the coming year.
We are building a more connected system that bridges acute and post-acute settings by uniting insights across the continuum. The insights empower clinicians with the information they need at the moment they need it, resulting in faster, safer, and more human-centered care.
A future where ambient technology is integrated across all hospital spaces — patient rooms, ORs, even waiting areas — will revolutionize decision-making to improve care.
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
In this episode, we're joined by Liz Powell, founder of Women's Health Advocates. We discussed the organization's policy priorities in the women's health space.
No comments